CytomX Therapeutics Balance Sheet (2014-2025) | CTMX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	329.67M	256.15M	236.28M	205.53M	163.49M	129.29M	95.03M	193.65M	56.36M	57.54M	26.02M	17.17M	36.19M	43.25M	40.58M	38.05M	47.60M	49.04M	34.19M	12.67M
Short-term Investments (Quarter)	64.13M	10.03M	0.01M	99.70M	99.04M	98.88M	99.25M		148.15M	123.32M	168.09M	157.34M	114.10M	93.94M	77.01M	62.57M	32.28M	109.05M	109.44M	124.39M
Cash & Current Investments (Quarter)	393.80M	266.18M	236.29M	305.23M	262.53M	228.16M	194.29M	193.65M	204.50M	180.86M	194.11M	174.51M	150.28M	137.18M	117.59M	100.62M	79.89M	158.09M	143.63M	137.05M
Receivables - Net (Quarter)	0.76M	0.93M	0.89M	0.79M	1.02M	1.01M	1.71M	35.99M	1.09M	1.90M	2.42M	3.43M	13.18M	2.77M	3.35M	3.10M	1.96M	1.87M	1.63M	2.01M
Receivables - Other (Quarter)	0.80M	0.90M	0.90M	0.80M	1.00M	1.00M	1.70M	35.00M	1.00M	1.30M	1.30M	2.20M	12.10M	1.50M	1.10M	1.10M	1.00M	1.20M	1.10M	0.90M
Receivables (Quarter)	1.56M	1.83M	1.79M	1.59M	2.02M	2.01M	3.41M	70.99M	2.09M	3.20M	3.72M	5.63M	25.28M	4.28M	4.45M	4.20M	2.96M	3.07M	2.73M	2.91M
Prepaid Assets (Quarter)	5.46M	3.90M	3.82M	4.29M	4.90M	3.59M	4.28M	7.47M	6.68M	5.04M	4.67M	5.00M	3.79M	3.12M	3.24M	3.58M	4.79M	4.67M	3.96M	4.86M
Current Assets (Quarter)	400.01M	271.00M	241.00M	310.30M	268.44M	232.77M	200.28M	237.10M	212.28M	187.80M	201.20M	182.94M	167.25M	143.08M	124.18M	107.31M	86.63M	164.62M	149.22M	143.92M
Non-Current Assets
Construction in Progress (Quarter)				0.31M				0.70M				0.37M
Property, Plant & Equipment (Net) (Quarter)	7.17M	6.70M	6.27M	5.96M	6.09M	5.92M	5.71M	5.07M	4.57M	4.50M	4.06M	3.96M	3.57M	3.32M	2.94M	2.47M	2.23M	1.95M	1.72M	1.30M
Long-Term Investments (Quarter)		99.91M	99.97M
Goodwill (Quarter)	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M	0.95M
Intangibles (Quarter)	1.13M	1.09M	1.06M	1.02M	0.98M	0.95M	0.91M	0.88M	0.84M	0.80M	0.77M	0.73M	0.69M	0.66M	0.62M	0.58M	0.55M	0.51M	0.47M	0.44M
Goodwill & Intangibles (Quarter)	2.08M	2.04M	2.01M	1.97M	1.93M	1.90M	1.86M	1.82M	1.79M	1.75M	1.72M	1.68M	1.64M	1.60M	1.57M	1.53M	1.50M	1.46M	1.42M	1.39M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.92M	0.92M	0.92M	0.92M	0.92M	0.92M	0.92M	0.03M	0.03M	0.92M	0.09M	0.08M	0.08M	0.92M	1.03M	1.03M	1.03M	0.06M	1.03M	0.03M
Non-Current Assets (Quarter)	34.15M	131.44M	130.24M	29.11M	28.38M	27.32M	26.21M	23.79M	22.35M	21.38M	19.96M	18.86M	17.44M	16.14M	14.80M	13.23M	11.87M	10.44M	9.04M	7.64M
Assets (Quarter)	434.16M	402.44M	371.23M	339.41M	296.82M	260.09M	226.49M	260.89M	234.63M	209.19M	221.17M	201.79M	184.69M	159.22M	138.98M	120.53M	98.50M	175.06M	158.25M	151.57M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.58M	1.75M	1.52M	2.82M	1.72M	1.92M	5.18M	2.81M	2.20M	1.03M	1.71M	1.46M	1.96M	0.61M	1.42M	1.09M	0.28M	0.23M	0.65M	1.30M
Payables (Quarter)	2.58M	1.75M	1.52M	2.82M	1.72M	1.92M	5.18M	2.81M	2.20M	1.03M	1.71M	1.46M	1.96M	0.61M	1.42M	1.09M	0.28M	0.23M	0.65M	1.30M
Accumulated Expenses (Quarter)	5.04M	5.80M	7.82M	34.24M	5.82M	7.11M	31.34M	8.06M	4.37M	5.44M	20.69M	8.16M	4.86M	5.74M	7.41M	2.58M	3.82M	11.50M	6.42M	14.20M
Other Accumulated Expenses (Quarter)	0.82M	0.93M	0.55M	0.71M	0.94M	0.14M	0.18M	0.26M	0.36M	0.16M	0.34M	0.31M	0.46M	0.20M	0.29M	0.49M	0.06M	0.11M	0.34M	0.14M
Short term Debt (Quarter)
Current Leases (Quarter)				3.62M	3.73M	3.85M	3.96M	4.08M	4.20M	4.33M	4.46M	4.59M	4.72M	4.86M	5.00M	5.14M	5.29M	5.44M	5.60M	4.24M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)	43.52M	39.31M	40.84M	284.76M	276.73M	264.89M	255.46M	301.33M	4.00M	261.15M	236.66M	212.31M	183.37M	160.48M	129.62M	94.06M	49.44M	11.60M	22.38M	28.50M
Total Current Liabilities (Quarter)	64.93M	60.32M	67.53M	77.87M	87.40M	94.64M	123.64M	152.61M	151.26M	141.38M	146.79M	155.91M	144.54M	142.86M	119.23M	85.77M	50.20M	39.22M	41.03M	46.62M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)	267.75M	264.09M	254.26M	243.94M	222.09M	203.91M	168.33M	180.06M	157.13M	140.87M	112.26M	80.05M	59.74M	36.71M	33.56M	26.86M	16.21M	10.24M	5.54M	1.59M
Preferred Stock Liabilities (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	20.81M	19.92M	19.02M	18.06M	17.08M	16.08M	15.05M	13.97M	12.87M	11.75M	10.60M	9.38M	8.15M	6.88M	5.60M	4.24M	2.86M	1.44M
Other Non-Current Liabilities (Quarter)										0.22M	2.76M	3.89M	3.94M	3.99M	4.05M	4.12M	4.18M	4.24M	4.30M	4.35M
Total Non-Current Liabilities (Quarter)						314.62M		346.64M		294.00M	269.65M	245.35M	212.43M	186.45M	158.38M	116.87M	69.27M	50.91M	46.57M	48.20M
Total Liabilities (Quarter)	353.49M	344.33M	340.80M	339.87M	326.56M	314.62M	307.03M	346.64M	321.27M	294.21M	272.40M	249.24M	216.37M	190.45M	162.43M	120.99M	73.45M	55.15M	50.87M	52.56M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	80.67M	58.11M	30.43M	-0.46M	-29.74M	-54.54M	-80.54M	-85.75M	-86.64M	-85.03M	-51.24M	-47.45M	-31.68M	-31.23M	-23.45M	-0.46M	25.05M	119.91M	107.39M	99.01M
Shareholder's Equity (Quarter)	80.67M	58.11M	30.43M	-0.46M	-29.74M	-54.54M	-80.54M	-85.75M	-86.64M	-85.03M	-51.24M	-47.45M	-31.68M	-31.23M	-23.45M	-0.46M	25.05M	119.91M	107.39M	99.01M
Liabilities and Shareholders Equity (Quarter)	434.16M	402.44M	371.23M	339.41M	296.82M	260.09M	226.49M	260.89M	234.63M	209.19M	221.17M	201.79M	184.69M	159.22M	138.98M	120.53M	98.50M	175.06M	158.25M	151.57M
Retained Earnings (Quarter)	-531.02M	-557.76M	-588.74M	-623.56M	-655.54M	-685.04M	-714.10M	-722.88M	0.03M	0.04M	-0.06M	-723.45M	-709.66M	-716.19M	0.04M	-691.58M	-668.05M	-668.21M	0.10M	0.11M
Preferred Shares (Quarter)
Treasury Shares (Quarter)				0.87M	0.98M	0.99M	0.40M	0.38M	1.69M	1.06M	1.44M	1.40M	1.69M	1.82M	1.82M	1.85M	2.79M	0.58M	1.00M	2.91M

Research Tools

CytomX Therapeutics Balance Sheet (2014-2025) | CTMX

Create an account

Sign In

Reset Password